For executives with more product, software, AI and automation initiatives than capacity. We compare expected benefits, lifecycle cost, adoption, risk, dependencies, technical debt and option value across the portfolio, so leadership can fund, test, sequence, defer or stop initiatives deliberately, and the economic case is made before the technical commitment scales.
These are the recognised moments when technology spending outruns the evidence behind it: select the ones you recognise.
Every cycle without a shared economic basis, the portfolio drifts toward the best-argued initiatives rather than the most valuable ones, and sunk costs make each wrong commitment harder to unwind than the last.
Most technology portfolios are not short of ideas. They are short of a shared way to compare them. A proposal with an enthusiastic sponsor and a confident benefits slide competes against a quiet piece of technical-debt work that would make everything else cheaper, and the louder case usually wins. This practice puts every initiative through the same economic lens: what value it creates and by which pathway, what it truly costs across its whole life rather than just its build, what the alternatives are, and what evidence it must produce before it earns more money. Not all value has to be immediate cash return: productivity, risk reduction and option value (the value of keeping a future choice open at a small cost today) all count, but every kind of value has to be named, so it can be tested rather than assumed.
The output is a set of funding decisions leadership can defend, not a scoring spreadsheet.
Commit properly to the initiatives whose value pathway, lifecycle cost and evidence justify it, and stop starving them to keep weaker ideas alive.
Route uncertain initiatives to a pilot with predefined success criteria, buying evidence before buying the build.
Order the portfolio by dependency and capacity as well as value, so early work genuinely unlocks later work.
Park initiatives whose case improves with time (falling costs, maturing technology, clearer demand) with the reasons and revisit date recorded.
End initiatives whose evidence has failed the gate, and recover the capacity. Sunk costs argue for nothing.
Choose the sourcing route on conditions, reversibility and vendor concentration, not on default preference.
The analysis runs on what your teams already know (initiatives, estimates, assumptions and criteria) assembled onto one comparable basis.
We agree with leadership what is actually being decided (an annual portfolio, a single major commitment, a pilot set) and the explicit criteria and weights the evaluation will use.
Initiatives, technical estimates, adoption assumptions, expected benefits and dependencies are collected from sponsors and delivery teams onto one comparable basis, including the debt and replacement work that never had a business case.
Each initiative is mapped to its value pathways with the measure that would prove each claim, and costed across its full life: build, integration, migration, training, operation, support and exit.
For the material commitments we compare the realistic sourcing routes (build, buy, partner, license, configure, defer, retire) on conditions, dependencies, reversibility and vendor concentration.
The portfolio is scored against the agreed criteria in a working session, so disagreements surface against the evidence, and the final sequence is one the executive has argued through, not received.
Funded initiatives leave with stage gates, minimum success criteria and a benefits-realisation plan with named owners: the mechanism that keeps the portfolio honest after we leave.
Innovation and strategy generate the options; this practice prices, prioritises and gates them; engineering and measurement carry the survivors forward.
Owns: value pathways · lifecycle cost · option comparison · portfolio prioritisation · stage gates.
The portfolio needs better options, not just better evaluation of existing ones.
The innovation pipeline: new products, services and propositions.
Innovation generates the initiatives; this practice prices and prioritises them.
Payment Processing Cost Reduction. An ecommerce retailer was losing a significant percentage of revenue to payment processing and invoice platform fees. Web Lifter redesigned the entire sales and payment workflow, replacing Stripe and Paycove with a direct Westpac PayWay integration and a custom-built invoicing platform. The new architecture reduced transaction costs, streamlined operations, and delivered immediate profit improvements without requiring any increase in sales volume.
Read the case“We can't recommend Web Lifter highly enough … a digital partner who could understand our operations, connect the dots between marketing and backend systems, and deliver real results.”
Consistency and teeth. Most business cases are written by sponsors to win funding, so each uses the assumptions that flatter it. This practice puts every case on one comparable basis (same value pathways, same lifecycle costing, same evidence standards) and attaches stage gates so the case is tested after approval, not just before it.
It usually protects them. Speculative work is exactly where option value and staged funding matter: instead of demanding a full revenue case a genuine experiment cannot provide, we fund the next slice of evidence with a clear gate. What the analysis does kill is speculation dressed up as a sure thing.
No. The same lenses apply to a single commitment: value pathways, lifecycle cost, option comparison and a staged approach to the commitment itself. Portfolio prioritisation only enters when there are genuinely competing uses for the capital and capacity.
By naming the pathway and the measure that would prove it. Productivity is valued in capacity released, risk reduction in exposure retired, avoided cost in spending that will not be needed. What we don't do is convert everything into a single speculative dollar figure: a labelled, testable claim beats a precise fiction.
The value of keeping a choice open. Paying a small amount now for the ability (but not the obligation) to move later, once you know more. A pilot that costs little but tells you whether a large market is real carries option value well beyond its direct return, and initiatives that lock you in destroy it. We make that value explicit so it can compete fairly in the portfolio.
As an unpriced liability that taxes future work. Debt items enter the same inventory as features, costed by what they add to every future initiative that touches them, which is usually the argument they were missing. Some debt is worth carrying; the point is deciding that deliberately.
The initiative list, technical estimates, adoption assumptions, expected benefits, known dependencies and the executive's decision criteria. None of it needs to be polished: surfacing the gaps and inconsistencies in those inputs is part of the analysis, not a barrier to it.
Not within this engagement: evaluation and delivery are kept deliberately separate, so the analysis has no incentive to recommend building. When an initiative clears its gate, our Engineering practice can deliver it, with the stage-gate criteria and benefits plan travelling along.
Scope depends on the size of the portfolio and the depth the material commitments need: a single-commitment review is a different engagement from an annual portfolio round. Both are fixed-scope, with deliverables agreed on a scoping call before work starts.
Funded initiatives leave with stage gates and a benefits-realisation plan; deferred ones leave with recorded reasons and a revisit date. Builds route to Engineering, pilots that need credible impact measurement route to Econometrics & Causal Analysis, and cases resting on fragile assumptions route to Sensitivity & Stress Testing before commitment.
You do: that is what the gates and the benefits plan are for. Each gate has predefined criteria and each benefit a named owner, so the next portfolio round starts from what was actually realised rather than what was promised.